BIOD-123

DRUG2 trials

Sponsors

Biodel

Conditions

Diabetes MellitusType 1 Diabetes Mellitus

Phase 1

Pharmacokinetic and Pharmacodynamic Properties of BIOD-123 and BIOD-125 Compared to Humalog® in Subjects With Type 1 Diabetes Including Assessments of Injection Site Toleration

CompletedNCT01908894

BiodelDiabetes Mellitus

Start: 2012-02-29End: 2012-03-31Updated: 2013-07-26

Phase 2

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®)

CompletedNCT01686620

BiodelType 1 Diabetes Mellitus

Start: 2012-08-31End: 2013-06-30Updated: 2015-07-28